LOINC | LOINC INTERPRETATION |
50595-8 | Pathologist Interpretation of Specimen tests |
48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
31208-2 | Specimen Source |
67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
18718-7 | Cell marker studies (set); CDO Markers used |
33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
69052-9 | Flow Cytometry specialist review of results |
55230-7 | Immunophenotyping study: Flow Cytometry report |
19139-5 | Pathologist name |
Result Test ID | Reportable | Result Test Name | Result Type | Type (Alpha or Numeric) |
SFCSF | N | SPECIMEN TYPR | I | A |
SFHIS | N | CLINICAL HISTORY | I | A |
SFDOC | N | NAME OF ONOCOLOGIST | I | A |
FLOW3 | N | FLOW CYTOMETRY,CSF | I | A |
LOINC | LOINC INTERPRETATION |
50595-8 | Pathologist Interpretation of Specimen tests |
48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
31208-2 | Specimen Source |
67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
18718-7 | Cell marker studies (set); CDO Markers used |
33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
69052-9 | Flow Cytometry specialist review of results |
55230-7 | Immunophenotyping study: Flow Cytometry report |
19139-5 | Pathologist name |
Specimen Requirements |
Testing |
Result Interpretation |
Coding |
LOINC | LOINC INTERPRETATION |
50595-8 | Pathologist Interpretation of Specimen tests |
48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
31208-2 | Specimen Source |
67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
18718-7 | Cell marker studies (set); CDO Markers used |
33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
69052-9 | Flow Cytometry specialist review of results |
55230-7 | Immunophenotyping study: Flow Cytometry report |
19139-5 | Pathologist name |
URM Labs Internal |
Test Build |
Result Test ID | Reportable | Result Test Name | Result Type | Type (Alpha or Numeric) |
SFCSF | N | SPECIMEN TYPR | I | A |
SFHIS | N | CLINICAL HISTORY | I | A |
SFDOC | N | NAME OF ONOCOLOGIST | I | A |
FLOW3 | N | FLOW CYTOMETRY,CSF | I | A |
LOINC | LOINC INTERPRETATION |
50595-8 | Pathologist Interpretation of Specimen tests |
48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
31208-2 | Specimen Source |
67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
18718-7 | Cell marker studies (set); CDO Markers used |
33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
69052-9 | Flow Cytometry specialist review of results |
55230-7 | Immunophenotyping study: Flow Cytometry report |
19139-5 | Pathologist name |